Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

April 24, 2025 08:05 ET | Source: VivoSim Labs, Inc.

VivoSim Announces Emergence from Stealth Mode To Provide Technologies for FDA Turn Away from Animal Models, $10B+ Market

SAN DIEGO, April 24, 2025 (GLOBE NEWSWIRE) -- VivoSim Labs, Inc. (Nasdaq: VIVS) (the “Company”) announced that it has emerged from stealth mode to dramatically impact drug discovery and development....
April 23, 2025 08:05 ET | Source: Organovo, Inc.

VivoSim to Carry Forward Organovo 3D Bioprinting

SAN DIEGO, April 23, 2025 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (Nasdaq: ONVO) (the “Company”) announced that it will carry forward its 3D bioprinting and legacy technology as VivoSim Labs,...
April 08, 2025 08:30 ET | Source: MarketsandMarkets Research Pvt. Ltd.

3D Bioprinting Market Worth US$2.4 billion | MarketsandMarkets™.

Delray Beach, FL, April 08, 2025 (GLOBE NEWSWIRE) -- 3D Bioprinting Market, valued at US$1.2 billion in 2023, is forecasted to grow at a robust CAGR of 12.7%, reaching US$1.3 billion in 2024 and an...
April 02, 2025 08:05 ET | Source: Organovo, Inc.

Organovo Provides Update on Cash and Nasdaq Continued Listing Requirements

SAN DIEGO, April 02, 2025 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (Nasdaq: ONVO) (“Organovo” or the “Company”), a clinical stage biotechnology company focused on developing novel treatment...
March 27, 2025 08:05 ET | Source: Organovo, Inc.

Organovo Provides Business Update

SAN DIEGO, March 27, 2025 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (Nasdaq:ONVO) (“Organovo” or the “Company”), a clinical stage biotechnology company focused on developing novel treatment...
December 23, 2024 10:40 ET | Source: Research and Markets

Amniotic Membrane Strategic Analysis Report 2024-2030: Market to Reach $13 Billion from $4.9 Billion - Growing Focus on Non-Immunogenic and Biocompatible Biomaterials Strengthens Business Case

Dublin, Dec. 23, 2024 (GLOBE NEWSWIRE) -- The "Amniotic Membrane - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.The global market for Amniotic...
November 13, 2024 08:06 ET | Source: Organovo, Inc.

Organovo to Present Clinical Data of FXR314 in Phase 2 MASH in an Oral Presentation at The Liver Meeting Sponsored by the American Association for the Study of Liver Diseases

SAN DIEGO, Nov. 13, 2024 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (Nasdaq:ONVO), a clinical stage biotechnology company focused on developing novel treatment approaches in inflammatory bowel...
October 23, 2024 04:02 ET | Source: Research and Markets

3D Bioprinting Market Industry Trends and Global Forecasts, 2019, 2024 and 2035: Advancements in Biomaterials and AI Integration, & Partnerships and Collaborations Propel the $4 Billion Market

Dublin, Oct. 23, 2024 (GLOBE NEWSWIRE) -- The "3D Bioprinting Market Industry Trends and Global Forecasts to 2035: Distribution by Type of Component, Type of Consumable, Type of Technology, Type of...
September 16, 2024 03:47 ET | Source: Exactitude Consultancy

3D Bioprinting Market valued at USD 1.41 billion in 2024 | ExactitudeConsultancy

Luton, Bedfordshire, United Kingdom, Sept. 16, 2024 (GLOBE NEWSWIRE) -- Exactitude Consultancy, the market research and consulting wing of Ameliorate Digital Consultancy Private Limited has...
June 10, 2024 06:55 ET | Source: Research and Markets

Wound Skin Substitutes Market Global Analysis to 2030, Featuring Coloplast, Smith & Nephew, MTF Biologics, MiMedx, AlloSource, Organogenesis, RTI Surgical, LifeNet Health and Molecular Biologicals

Dublin, June 10, 2024 (GLOBE NEWSWIRE) -- The "Wound Skin Substitutes Market - A Global and Regional Analysis: Focus on Region, Country-Level Analysis, and Competitive Landscape - Analysis and...

Next Page keyboard_arrow_right